11.00 Registrations

11:30-13.00 The Most Impactful Antithrombotic Trials in 2020-2021 Highlights from ACC 21


Chair: George Hahalis


Michail Botis


Gregory Pattakos


John Goudevenos


Theodora Bampali


Petroula Nana


Dimitrios Nikas


Dimitrios Alexopoulos


Alexandros Tselepis

13.00-14.30 Clinical Seminar: Uncertainties and challenges in anticoagulation therapy

Moderators: John Goudevenos, Haralampos Milionis

A patient with renal insufficiency - What is the optimal anticoagulation?

Dimitrios Vlahakos

Subclinical atrial fibrillation is detected in a patient - When to anticoagulate?

Konstantinos Zekios

Anticoagulant Reversal Agents: Who, What, When, and How?
Christos Katsouras

Cardiac Surgery in the COVID-19 Era

Dimitrios Iliopoulos

Choice of anticoagulant therapy in coexisting clinical diseases. Α clinical case of a 75 year old woman

Konstantinos Vemmos

Discussants: Vasileios Primikiris, Theodora Bampali, Vasileios Bellos

14.30-15.30 Coffee Break

15.30-17.00 Indications, contraindications, and precautions with the use of DOACs

Chairs: Georgios Kochiadakis, Georgios Tsivgoulis

Use of DOACs in Patients with AF and Valvular Heart Lesions

Dimitrios Richter

DOACs in adults with congenital heart disease

Eugenia Tsagalidou

Anticoagulation and Stroke Prevention for AF: Stroke Prophylaxis in Complicated Cases

Odysseas Kargiotis

End-Stage Renal Disease and Haemodialysis. Antiplatelets - Anticoagulants

Konstantinos Siontis (USA)

Discussants: Georgios Kalambokis, Dimitrios Nikolopoulos, Sotirios Mitsiadis

17.00-17.30 Break

17.30-19.00 Meet the Experts. Stroke management: specific issues


Chairs: Georgios Tsivgoulis, Sotirios Giannopoulos

Intravenous Thrombolysis for acute ischemic stroke: ESO recommendations

Georgios Tsivgoulis

How to Manage a Patient after Thrombolysis and Mechanical Thrombectomy

Panagiotis Mitsias

The uncertainty of timing of anticoagulation initiation after cardioembolic Stroke

Sotirios Giannopoulos

Restarting stroke prevention treatment in intracranial hemorrhage survivors

John Ellul

19.00-20.00 Plenary Session. COVID-19 coagulopathy: What we know and how to treat

Chairs: Alex Spyropoulos (USA), Alexandros Tselepis

The unique characteristics of COVID-19 coagulopathy

Efrosyni Nomikou

Coagulation Tests in COVID-19 patients: When to perform -risk stratification

Vasiliki Danilatou

Management of coagulopathy in COVID-19 patients. Recent advances

Elias Kiriakou

Discussant: Katerina Panteli

20.00-20.20 Keynote Lecture

Chair: Kostas Toutouzas

Virtual management of thrombosis and anticoagulation: the way of the future?

James Douketis (Canada)

20.20-20.45 Official Opening of ALPIC 2020

Chairs: Alexandros Tselepis, John Goudevenos, Haralampos Milionis

Vice Rector of the University of Ioannina

Minas Paschopoulos

President of the EMLTD Society

Alexandros Tselepis

President of the Hellenic Society of Cardiology

John Kanakakis

Vice President of the Institute for the Study and Education on Thrombosis and Antithrombotic Therapy

Miltiadis Matsagkas

Mayor of Kalavrita

Athanasios Papadopoulos

Respected Metropolitan of Kalavrita


20.45-21.10 Opening Lecture

Chair: Alexandros Tselepis

The Psychological and Social Impact of the Quarantine in COVID-19 Pandemic

Thanos Askitis

08.30-10.00 How to Treat Session. Practical Guidance in Antithrombotic Therapy

Moderators: Dimitrios Alexopoulos, Anastasios Spanos

Managing Tough Anticoagulation Cases - What Would YOU Do?

Kalliroi Kalantzi

A 60 Years Old Patient with Pancreatic Cancer Who Develops A Pulmonary Embolism

Konstantinos Pappas

A 70 Years Old Patient with ESRD and Atrial Fibrillation

Athanasios Pipilis

Α pregnant woman with mechanical valve thrombosis

Gregory Pattakos

The do’s and the don’ts in a hypertensive patient with Transient ischemic attack

Christos Savopoulos

10.00-10.30 Break

10.30-11.30 Advanced Clinical Workshop: Antithrombotics in Coronary Artery Disease

Chairs: Periklis Davlourοs, Fragiskos Parthenakis

Antithrombotic Treatment before, during and after PCI

Dimitrios Alexopoulos

Bleeding after an ACS: what are you doing with the antithrombotic therapy

Eugenia Pappa

Antithrombotic therapy for patients with chronic coronary syndromes

John Kanakakis

Discussants: Despoina Pantazi, Louiza Peclivani

11.30-12.00 Satellite Lecture Pfizer

Chair:John Goudevenos

Up to date on anticoagulant therapy in patients with Acute Coronary Syndrome/ PCI in atrial fibrillation.

Leonidas Poulimenos

12.00-13.30 Meet the Experts session: Risk assessment of thrombosis in hematological disorders

Chairs: Eleftheria Hatzimichael, Efrosyni Nomikou

Thromboinflammation and sickle cell disease

Efthimia Vlachaki

Multiple myeloma - associated coagulopathy

Evdoxia Hatjiharissi

Thrombotic complications of myeloproliferative neoplasms

Elissavet Grouzi

PNH associated thrombosis

Styliani Kokkori

Mechanisms and management of coagulopathy in acute promyelocytic leukemia

Vassilios Perifanis

13.30-14.30 Clinical Seminar. Management of acute ischemic stroke

Chairs: Konstantinos Vemmos, Eleni Koromboki

Dissolving the thrombus

Vasilios Papavasileiou

Dissolving the thrombus in a patient on anticoagulation

Georgios Ntaios

Retrieving the embolus

Panagiotis Papanagiotou

14.30-15.30 Break

15.30-17.00 Plenary session: New Insights in Cancer-Associated Thrombosis (CAT)

Chair: Alexandros Tselepis

Pathophysiological mechanisms underlying CAT

Alexandros Tselepis

Biomarkers for CAT prediction

Benjamin Brenner (Israel)

Treatment of bleeding in cancer patients

Stavroula Tsiara

Anticoagulants in CAT. When to choose a LMWH or a DOAC?

Miltiadis Matsagkas

Prevention and treatment of CAT practice guidelines. Consensus or Confusion?

James Douketis (Canada)

Discussants: AIkaterini Pappa, Virginia Blani

17.00-17.30 Break

17.30-19.30 Meet the Experts. Perioperative Management of Antithrombotics

Chairs: John Goudevenos, Eleni Arnaoutoglou

Perioperative management of antiplatelets. An update

Petros Tzimas

Thromboprophylaxis in Orthopaedic interventions

Anastasios Korompilias

VTE prevention for patients undergoing major Surgery for gastrointestinal and hepato-pancreato-biliary malignancies

Georgios Glantzounis

Perioperative myocardial infarction in the twilight zone between a surgeon and a cardiologist. The role of anaesthesiologist

Eleni Arnaoutoglou

DOACs Timing of interruption before elective procedures or surgery

Dimitrios Nikas

DAPI in PAD. Just indications or evidence?

Miltiadis Matsagkas

Perioperative anticoagulant management: what have we learned in 2020?

James Douketis (Canada)

19.30-19.50 Keynote Lecture

Chairs: James Douketis (Canada), Fragiskos Parthenakis

Anticoagulant Strategies for Thromboprophylaxis in Sick, Hospitalized COVID-19 Patients

Alex Spyropoulos (USA)

19.50-21.20 Plenary Session. New insights into the role of PCSK9 and Lipoproteins in Atherosclerosis and Thrombosis. From Pathophysiology to Therapy

A joint session of EMLTD with Hellenic Atherosclerosis Society

Chairs: Alexandros Tselepis, Evangelos Liberopoulos

PCSK9 in Atherosclerosis and Thrombosis - Lipids and Beyond

Alexandros Tselepis

HDL as an Antiatherogenic and Antithrombotic Lipoprotein. Recent Advances

Kyriakos Kypreos

Eligibility for PCSK9 Inhibitors Treatment in ACS and chronic coronary artery disease

Evangelos Liberopoulos

Stroke Prevention with PCSK9 Inhibitors

Haralampos Milionis

Efficacy and Safety of PCSK9 Inhibitors in Patients with Low Extremity

Arterial Disease

Vasileios Kotsis

The Effect of PCSK9 Inhibition on the VTE Risk

Theodosios Filippatos

Discussants: Amalia Despoina Koutsogianni, Katerina Tsouka

09.00-11.00 Pathogenesis of ischemic stroke: Heart and Vessels

Chairs: Haralampos Milionis, Christos Savopoulos, Athanassios Protogerou

Secondary prevention in patients with cryptogenic stroke and PFO

Nikolaos Kakaletsis

Atrial cardiomyopathy and ischemic stroke: definition, relationships and antithrombotic treatment

Panagiotis Korantzopoulos

Lipid lowering treatment in the secondary prevention of ischemic stroke

Fotios Barkas

Non-stenotic atheromatous plaques and cryptogenic embolic stroke: potential relationship, attributable risk and management

Matilda Florentin

Anemia and stroke: Where do we stand?

Georgia Kaiafa

COVID-19 and ischemic stroke

Dimitrios Sagris

11.00-11.30 Break

11.30-12.30 Challenging the risk and management in Women Thrombosis

Chairs: Minas Paschopoulos

Hormones, venous and arterial thrombosis in Women

Ploutarchos Tzoulis

To screen or not to screen for thrombophilia in a Pregnant Women or in a Women trying to conceive?

Eleftheria Lefkou

Thrombosis in pregnancy: Prophylaxis and treatment

Sue Pavord (UK)

12.30-14.30 Plenary Session. Recent Advances in VTE pathophysiology and treatment

A special session organized by the EMLTD Executive Board

Chairs:Lina Badimon (Spain), Alexandros Tselepis

New insights into the pathophysiology of VTE

Teresa Padró (Spain)

Contribution of thrombophilia to the development of chronic thromboembolic pulmonary hypertension (CTEPH)

Vittorio Pengo (Italy)

How to treat pediatric venous thromboembolic disease

Gili Kenet (Israel)

Managing pulmonary embolism posthospital discharge

Joao Morais (Portugal)

You can download the Scientific Program HERE